CLINICAL AND ECONOMIC IMPACT OF BLOOD CULTURES AMONG ADULT PATIENTS ADMITTED WITH PNEUMONIA IN TIANJIN, CHINA
Author(s)
Yu N1, Wu J1, Li P2
1Tianjin University, Tianjin, China, 2Becton, Dickinson and Company, Shanghai, China
Presentation Documents
OBJECTIVES: Blood culture (BC) is a key diagnostic technique detecting bloodstream infections (BSI) that is a life-threatening condition. It also establishes the infectious etiology and initiates further antimicrobial susceptibility testing and therapy optimization. The present study aimed to examine the clinical and economic impact of BC among patients with pneumonia, one of the commonest diseases complicated by BSI, in Tianjin. METHODS: A retrospective observational study was conducted in two tertiary hospitals. We aimed to identify 300 balanced consecutively hospitalized adult patients with pneumonia diagnosis whom BC was obtained before August, 2015. Data were collected about patients’ demographics, clinical features, BC results and antibiotic regimens from their medical records. The results and costs of BC as well as the comparison between definitive antibiotic regimens and empiric therapies; including switching, addition, discontinuation or any change in dosage were reported. Finally, the antibiotics cost savings due to changing to alternatives based on BC results were evaluated. RESULTS: From
Conference/Value in Health Info
2016-09, ISPOR Asia Pacific 2016, Singapore
Value in Health, Vol. 19, No. 7 (November 2016)
Code
PMD4
Topic
Epidemiology & Public Health
Topic Subcategory
Disease Classification & Coding
Disease
Infectious Disease (non-vaccine)